000 | 01783 a2200505 4500 | ||
---|---|---|---|
005 | 20250513221812.0 | ||
264 | 0 | _c20001207 | |
008 | 200012s 0 0 eng d | ||
022 | _a0014-2999 | ||
024 | 7 |
_a10.1016/s0014-2999(00)00649-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGao, X | |
245 | 0 | 0 |
_aEffects of dopaminergic agents on carrageenan hyperalgesia in rats. _h[electronic resource] |
260 |
_bEuropean journal of pharmacology _cOct 2000 |
||
300 |
_a53-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzazepines _xpharmacology |
650 | 0 | 4 | _aCarrageenan |
650 | 0 | 4 |
_aDopamine Agents _xpharmacology |
650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aHindlimb |
650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 | _aInjections, Intraventricular |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPain _xprevention & control |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 |
_aQuinolines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
650 | 0 | 4 |
_aSodium Chloride _xpharmacology |
650 | 0 | 4 |
_aSpiperone _xpharmacology |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aZhang, Y | |
700 | 1 | _aWu, G | |
773 | 0 |
_tEuropean journal of pharmacology _gvol. 406 _gno. 1 _gp. 53-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(00)00649-x _zAvailable from publisher's website |
999 |
_c10956922 _d10956922 |